PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 27, 20261 citations

Association of type 2 diabetes treatment status with in vivo biomarkers of Alzheimer's disease.

View Full Paper
MAMuge AkinciFAFroogh AzizDGDiana Guzman

Key Points

  • This research aims to explore the connection between type 2 diabetes treatment status and Alzheimer’s disease biomarkers.
  • Analyzed the association between diabetes treatment and amyloid beta (Aβ) deposition.
  • Examined in vivo biomarkers for Alzheimer's disease in individuals with varying diabetes treatment status.
  • Untreated type 2 diabetes is associated with early amyloid beta deposition.
  • Treated type 2 diabetes does not show the same association with amyloid burden.

Abstract

Prediabetes/untreated T2D, but not treated T2D, was associated with early Aβ deposition. Diabetes medications may mitigate brain Aβ burden.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Akinci et al. (2026) studied this question.

synapsesocial.com/papers/69a13571ed1d949a99abf5bahttps://doi.org/10.1002/alz.71214
Ask AI
Helpful
Bookmark
Share
View Full Paper